Arcturus Therapeutics: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Line 1: Line 1:
'''Arcturus Therapeutics''' is a [[biotechnology]] company that specializes in the development of [[RNA medicines]]. The company's primary focus is on [[rare diseases]], [[viral infections]], and [[liver diseases]]. Arcturus Therapeutics utilizes a proprietary [[lipid nanoparticle]] delivery system known as LUNAR® to deliver its RNA medicines to cells.
{{Short description|Anatomical structure in the cardiovascular system}}
{{Anatomy}}


== History ==
The '''aortic body''' is a small cluster of [[chemoreceptor]]s, [[baroreceptor]]s, and supporting cells located along the [[aortic arch]]. It plays a crucial role in the regulation of respiratory and cardiovascular functions by monitoring changes in blood chemistry and pressure.
Arcturus Therapeutics was founded in 2013 by Joseph Payne and Pad Chivukula. The company was initially based in [[San Diego]], California. In 2020, Arcturus Therapeutics began clinical trials for a [[COVID-19]] vaccine, known as ARCT-021.


== Technology ==
==Structure==
Arcturus Therapeutics uses a proprietary lipid nanoparticle delivery system, LUNAR®, to deliver RNA medicines to cells. This technology allows for the targeted delivery of RNA medicines to specific cells in the body. The company also utilizes a proprietary RNA engineering platform, STARR™, to create RNA medicines that can be used to treat a variety of diseases.
The aortic body is situated near the heart, specifically at the arch of the [[aorta]], which is the major artery that carries blood away from the heart to the rest of the body. It is composed of a collection of cells that are sensitive to changes in the partial pressure of [[oxygen]] (pO2), carbon dioxide (pCO2), and the pH of the blood.


== Products ==
==Function==
Arcturus Therapeutics has several products in its pipeline, including treatments for rare diseases, viral infections, and liver diseases. The company's most advanced product is ARCT-021, a vaccine for COVID-19 that is currently in clinical trials.
The primary function of the aortic body is to detect changes in the blood's chemical composition. It is particularly sensitive to hypoxia (low oxygen levels), hypercapnia (high carbon dioxide levels), and acidosis (low pH). When such changes are detected, the aortic body sends signals to the [[medulla oblongata]] in the brainstem, which in turn adjusts the rate and depth of [[respiration]] to maintain homeostasis.


== Clinical Trials ==
The aortic body also contains baroreceptors that help regulate blood pressure by detecting changes in the stretch of the aortic wall. These receptors send signals to the brain to modulate heart rate and vascular resistance, thus maintaining stable blood pressure.
Arcturus Therapeutics has conducted several clinical trials to test the safety and efficacy of its products. The most notable of these is the ongoing trial for ARCT-021, the company's COVID-19 vaccine.


== See Also ==
==Clinical significance==
* [[Biotechnology]]
Dysfunction of the aortic body can lead to impaired respiratory and cardiovascular responses. Conditions such as [[chronic obstructive pulmonary disease]] (COPD) and [[heart failure]] can affect the sensitivity of the aortic body, leading to inadequate responses to changes in blood gases.
* [[RNA medicines]]
* [[Lipid nanoparticle]]
* [[COVID-19 vaccine]]


== References ==
==Related pages==
<references />
* [[Carotid body]]
* [[Chemoreceptor]]
* [[Baroreceptor]]
* [[Aorta]]


[[Category:Biotechnology companies]]
==Gallery==
[[Category:Pharmaceutical companies]]
<gallery>
[[Category:Companies based in San Diego]]
File:Gray505.png|Location of the aortic body in relation to the aortic arch.
[[Category:Companies established in 2013]]
</gallery>


{{pharmacology-stub}}
[[Category:Cardiovascular system]]
[[Category:Respiratory physiology]]

Revision as of 17:43, 11 February 2025

Anatomical structure in the cardiovascular system


The aortic body is a small cluster of chemoreceptors, baroreceptors, and supporting cells located along the aortic arch. It plays a crucial role in the regulation of respiratory and cardiovascular functions by monitoring changes in blood chemistry and pressure.

Structure

The aortic body is situated near the heart, specifically at the arch of the aorta, which is the major artery that carries blood away from the heart to the rest of the body. It is composed of a collection of cells that are sensitive to changes in the partial pressure of oxygen (pO2), carbon dioxide (pCO2), and the pH of the blood.

Function

The primary function of the aortic body is to detect changes in the blood's chemical composition. It is particularly sensitive to hypoxia (low oxygen levels), hypercapnia (high carbon dioxide levels), and acidosis (low pH). When such changes are detected, the aortic body sends signals to the medulla oblongata in the brainstem, which in turn adjusts the rate and depth of respiration to maintain homeostasis.

The aortic body also contains baroreceptors that help regulate blood pressure by detecting changes in the stretch of the aortic wall. These receptors send signals to the brain to modulate heart rate and vascular resistance, thus maintaining stable blood pressure.

Clinical significance

Dysfunction of the aortic body can lead to impaired respiratory and cardiovascular responses. Conditions such as chronic obstructive pulmonary disease (COPD) and heart failure can affect the sensitivity of the aortic body, leading to inadequate responses to changes in blood gases.

Related pages

Gallery